Events
GRASP brings patients and researchers together for small-group conversations that make cancer science more accessible, collaborative, and deeply informed by patient experience.
Poster Walkthroughs are virtual small group sessions where advocates and researchers discuss posters from cancer conferences.
Group 4B: Biomarkers and Treatment Response in HR+ Breast Cancer
June 12 @ 10:00 am - 11:30 am
The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting is a global conference highlighting the latest advances in cancer research and care. GRASP provides a unique opportunity for advocates and clinical researchers to join the conversation through Poster Walkthroughs.
Register Below
This ASCO26 Poster Walkthrough group will explore key findings from the following posters:
Poster #1093: Association of ESR1 amplification with survival and benefit from CDK4/6 inhibition in breast cancer.
Poster #1079: Outcomes by lobular (lob) histology status at initial diagnosis in patients (pts) in the INAVO120 phase 3 trial with PIK3CA-mutated (mut), hormone receptor-positive (HR+), HER2-negative (HER2–), endocrine-resistant advanced breast cancer (aBC) treated with inavolisib (INAVO)/placebo (PBO) + palbociclib (PALBO) + fulvestrant (FULV).
Track: Breast Cancer—Metastatic | Subtrack: Hormone Receptor-Positive (HR+) | Keywords: ESR1, ILC, PI3K, Treatment resistance, Trial in progress

